|Bid||0.00 x 1200|
|Ask||0.00 x 1200|
|Day's Range||203.08 - 206.90|
|52 Week Range||200.47 - 276.69|
|Beta (5Y Monthly)||0.67|
|PE Ratio (TTM)||17.13|
|Earnings Date||Oct 26, 2021 - Nov 01, 2021|
|Forward Dividend & Yield||7.04 (3.23%)|
|Ex-Dividend Date||Aug 16, 2021|
|1y Target Est||250.00|
In the latest trading session, Amgen (AMGN) closed at $206.78, marking a +1.8% move from the previous day.
Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of Teneobio, Inc. (Teneobio). Effective as of Oct. 19, 2021, Amgen has acquired all outstanding equity of Teneobio in exchange for a $900 million upfront cash payment, as well as future contingent milestone payments, to former Teneobio equity holders potentially worth up to an additional $1.6 billion in cash.
These dividend stocks provide sustainable and growing dividends, which are nearly triple the S&P 500's yield.